Plans Regional Operational Hub and Supports Local SME Trade Settlements XTransfer, the World’s Leading B2B Cross-Border Trade Payment Platform, is pleased to announce that it has received conditional approval from Bank Negara Malaysia (BNM) for key payment licences, including issuing electronic money, as well as a Money Services Business Licence (Class A) covering remittance and […]
STÄFA, Switzerland, Feb. 26, 2026 (GLOBE NEWSWIRE) — Phonak, a global leader in innovative hearing solutions, will mark World Hearing Day on March 3 with a global campaign across three continents, putting youth hearing health at the center of the conversation. Together, with its three international ambassadors, Phonak inspires children and teens to protect their
Phonak ambassadors spotlight hearing health for the next generation on World Hearing Day GlobeNewswire February 26, 2026 STÄFA, Switzerland, Feb. 26, 2026 (GLOBE NEWSWIRE) — Phonak, a global leader in innovative hearing solutions, will mark World Hearing Day on March 3 with a global campaign across three continents, putting youth hearing health at the center
(Brussels:CMBT),(NYSE:CMBT), CMB.TECH ANNOUNCES Q4 2025 RESULTSEIGHT VLCCS SOLD AT STELLAR PRICES ANTWERP, Belgium, 26 February 2026 – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the company”) (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) reported its unaudited financial results today for the fourth quarter ended 31 December 2025. HIGHLIGHTS Financial highlights: Profit for the period
(Euronext Amsterdam:SBMO),(Pinksheets:SBFFF),(PinkSheets:SBFFF),(Pinksheets:SBFFY),(PinkSheets:SBFFY), Amsterdam, February 26, 2026 Setting industry benchmarks, increasing shareholder returns Highlights Directional1 revenue of US$5.1 billion, above guidance Directional EBITDA of US$1.7 billion, above guidance US$31.1 billion Directional backlog; US$8.4 billion Directional net cash backlog2 Record cash return of US$2.57 per share3: US$200 million aggregate dividend4; US$270 million share repurchase5 Minimum US$2.1 billion
CMB.TECH ANNOUNCES Q4 2025 RESULTS – EIGHT VLCCS SOLD AT STELLAR PRICES GlobeNewswire February 26, 2026 CMB.TECH ANNOUNCES Q4 2025 RESULTSEIGHT VLCCS SOLD AT STELLAR PRICES ANTWERP, Belgium, 26 February 2026 – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the company”) (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) reported its unaudited financial results today
SBM Offshore Full Year 2025 Earnings GlobeNewswire February 26, 2026 Amsterdam, February 26, 2026 Setting industry benchmarks, increasing shareholder returns Highlights Directional1 revenue of US$5.1 billion, above guidance Directional EBITDA of US$1.7 billion, above guidance US$31.1 billion Directional backlog; US$8.4 billion Directional net cash backlog2 Record cash return of US$2.57 per share3: US$200 million aggregate
(NASDAQ:MOLN),(SWX:MOLN.SW), ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) — Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced it has entered into an agreement with Eckert & Ziegler, leading specialist in
(NASDAQ:MOLN),(SWX:MOLN.SW), ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) — Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced its attendance and presentations at upcoming investor conferences. Molecular Partners will also issue
(Brussels:ARGX),(NASDAQ:ARGX), $1.3 billion in fourth quarter and $4.2 billion in full year global product net sales, representing 90% yearâ€'overâ€'year growth Delivered $1.1 billion in operating income in 2025, marking first year of operating profitability VYVGART MG label expansion supported by positive ADAPT SERON and OCULUS results; PDUFA target action date of May 10, 2026 for